Are GLP-1 Medications Transforming Chronic Disease?

Why It Matters

Expanding affordable, clinically‑monitored GLP‑1 access could transform women’s chronic‑disease treatment and address the pervasive adherence gap in healthcare.

Key Takeaways

• GLP‑1 drugs treat chronic conditions, not just weight loss
• She Med runs largest real‑world study of women on GLP‑1s
• Participants report reduced inflammation, regular periods, improved fertility
• NHS limited access; private platforms provide affordable, monitored GLP‑1 therapy
• Medication adherence remains biggest unsolved challenge in chronic disease care

Summary

She Med’s video argues that GLP‑1 medications are a clinical breakthrough for chronic disease, especially for women with conditions like PCOS, rather than a cosmetic weight‑loss tool.

The company cites its large real‑world study showing participants experience reduced inflammation, regular menstrual cycles, lower testosterone, and improved fertility, while highlighting NHS supply constraints that leave many patients underserved.

The speaker stresses, “It’s clinical, not cosmetic,” and points out that adherence—keeping patients on therapy—is the biggest unsolved problem in medicine, noting that 60% discontinue for reasons unrelated to the drug itself.

If private health‑tech platforms can deliver affordable, clinician‑monitored GLP‑1 access, they could reshape chronic‑care management, reduce stigma, and improve long‑term outcomes for women worldwide.

Original Description

@shemed_uk is the first female-focused GLP-1 company in the UK with a mission to close the women's health research gap by examining the potential of these medications to address specific women’s health conditions, including PMOS, endometriosis, menopause symptoms, and other areas that remain under-researched.

GLP-1 medications are transforming how we think about chronic disease, yet up to 60% of patients quit within the first year. In her chat @sxswlondon, eMed CEO Linda Yaccarino makes the case that GLP-1s are not a weight loss story, they're a preventative care story.

Tap the link in bio to learn more about how GLP-1 drugs have transformed medicine

https://www.newscientist.com/article/2503480-the-potential-of-glp-1-drugs-to-transform-medicine-exploded-in-2025/